2019 MCW Pancreatic Cancer Clinical Symposium

January 25, 2019

Over 45,000 people in the US annually are affected by Pancreatic Cancer. It is the 9th most common type of cancer and is the second leading cause of cancer deaths in the US.  Understanding and targeting stage-specific management of pancreatic cancer is an important medical and public health issue.

 

The management of pancreatic cancer is rapidly changing with an increasing emphasis on neoadjuvant therapy for early stage pancreatic cancer and surgery is now being performed in select patients with more advanced staged disease.  This course is designed to provide practitioners a better understanding of the rationale and implementation of neoadjuvant therapy for pancreatic cancer and explore exciting new investigational approaches to the disease.

 

Management of pancreatic cancer can be complicated and confusing for several reasons:
  • There is not a standardized radiographic criteria for clinical staging, it can vary by clinical source or institution.
  • Management of pancreatic cancer frequently involves multi-disciplinary teams and coordination of multiple physicians can be complicated.
  • Stigma and perception from the general public about realistic survival, however, patients with pancreatic cancer are currently experiencing the most promising survival in the last 30 years.
This symposium provides background into the diagnosis and work-up of all stages of pancreatic cancer for clinicians who are not familiar with the management of this disease. In addition, the symposium will highlight the multimodality treatment options for all stages of pancreatic cancer.

 

 

 

 

Target Audience

  • Primary care physicians
  • Gastroenterologists
  • General surgeons
  • Surgical Oncologists
  • Medical oncologists
  • Radiation oncologists
  • Fellows, Residents, and Students
  • Allied Health Professionals

Learning Objectives

  1. Define the process of diagnosing and staging pancreatic cancer patients.
  2. Review multimodality stage-specific treatment sequencing based on clinical stage for patients with pancreatic cancer.
  3. Review current controversies in the management of locally advanced and localized pancreatic cancer.
Additional information

Contact

Name: 
Heidi Brittnacher
Phone Number: 
+1 (414) 955-1831
Email: 
[email protected]
Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 7.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
11/30/2018
Course expires: 
06/14/2019
Event starts: 
01/25/2019 - 8:00am CST
Event ends: 
01/25/2019 - 5:00pm CST
Cost:
$2.50
Add to calendar: 
Harley Davidson Museum - The Rumble Room
400 W. Canal Street
Milwaukee, WI
United States
Director: Susan Tsai, MD, MHS
Associate Professor, Surgical Oncology
 
Invited Speakers:
Ignacio Garrido-Laguna, MD, PhD
Associate Professor, GI Oncology
Associate Director, Phase 1 Program
Department of Internal Medicine, Division of Oncology
University of Utah School of Medicine Huntsman Cancer Institute

Christopher Crane, MD
Vice Chair, Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center
 
Medical College of Wisconsin Speakers:
Kathleen Christians, MD
Professor
Division of Surgical Oncology

Douglas Evans, MD
Donald C. Ausman Family Foundation Professor of Surgery
Professor and Chair
Department of Surgery

Ben George, MD
Associate Professor of Medicine
Division of Hematology and Oncology|

Jennifer Geurts, MS, CGC
Program Director I
Genetic Counseling Program

William Hall, MD
Assistant Professor
Department of Radiation Oncology

Abdul Khan, MD
Associate Professor
Department of Medicine

Parag Tolat, MD
Associate Professor
Department of Radiology

Susan Tsai, MD, MHS
Associate Professor
Division of Surgical Oncology
 

In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. Those in control of content had no relevant financial relationships to disclose with the exception of:

NameCompanyRole
Ignacio Garrido-LagunaTaiho Oncology, Glycyx Pharma & Iguyta Inc.Advisory Board
Christopher CraneCelgene & Trio HealthAdvisory Board
Ben GeorgeCelgene, Cook Medical, Ipsen, Exelixis, Merrimack Taiho Oncology, Terumo & BMSConsultant

These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 7.0 hours of participation for continuing education for allied health professionals.

Available Credit

  • 7.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 7.00 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$2.50
Please login or register to take this course.

This activity is complementary, however registration is required. To register for this course contact Heidi Brittnacher at (Tel: 414-955-1831 | Email: [email protected])

To receive continuing education credit, choose the appropriate credit type from the drop down menu above and click the "Add to Cart" button. A $25 fee for certification, plus a $2.50 processing fee is assessed if continuing education credits are requested.

The credit fee will be waived for the submission of interesting cases. Please contact Heidi Brittnacher for further information on complimentary registration if it applies to you. (Tel: 414-955-1831 | Email: [email protected])

Please note! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover.